Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Aortic Diseases

tetradecanoylphorbol acetate has been researched along with Aortic Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahrens, I; Aikawa, M; Bassler, N; Bavendiek, U; Bode, C; Ernst, S; Gerdes, N; Libby, P; MacFarlane, L; Maier, C; Missiou, A; Patko, Z; Peter, K; Schönbeck, U; Soosairajah, J; Zirlik, A1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Aortic Diseases

ArticleYear
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1.
    Circulation, 2007, Mar-27, Volume: 115, Issue:12

    Topics: Animals; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; CD40 Ligand; Chemotaxis, Leukocyte; CHO Cells; Cholesterol, Dietary; Cricetinae; Cricetulus; Crosses, Genetic; Diet, Atherogenic; Foam Cells; Genetic Predisposition to Disease; Humans; Inflammation; Lipids; Macrophage-1 Antigen; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Monocytes; Peritonitis; Peroxidase; Receptors, LDL; Rheology; Tetradecanoylphorbol Acetate

2007